| Literature DB >> 28322329 |
Ying Zhang1, Yuanming Feng1,2,3, Wei Wang2, Chengwen Yang1,2, Ping Wang2.
Abstract
A novel and versatile "bottom-up" approach is developed to estimate the radiobiological effect of clinic radiotherapy. The model consists of multi-scale Monte Carlo simulations from organ to cell levels. At cellular level, accumulated damages are computed using a spectrum-based accumulation algorithm and predefined cellular damage database. The damage repair mechanism is modeled by an expanded reaction-rate two-lesion kinetic model, which were calibrated through replicating a radiobiological experiment. Multi-scale modeling is then performed on a lung cancer patient under conventional fractionated irradiation. The cell killing effects of two representative voxels (isocenter and peripheral voxel of the tumor) are computed and compared. At microscopic level, the nucleus dose and damage yields vary among all nucleuses within the voxels. Slightly larger percentage of cDSB yield is observed for the peripheral voxel (55.0%) compared to the isocenter one (52.5%). For isocenter voxel, survival fraction increase monotonically at reduced oxygen environment. Under an extreme anoxic condition (0.001%), survival fraction is calculated to be 80% and the hypoxia reduction factor reaches a maximum value of 2.24. In conclusion, with biological-related variations, the proposed multi-scale approach is more versatile than the existing approaches for evaluating personalized radiobiological effects in radiotherapy.Entities:
Mesh:
Year: 2017 PMID: 28322329 PMCID: PMC5359554 DOI: 10.1038/srep45019
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flowchart of the expanded multi-scale Monte Carlo simulation.
Figure 2Diagram of geometries for TLK model calibration.
(a) Whole geometry for first MC simulation. (b) Six-well plate at the cellular level. (c) Longitudinal section of the ROI region. (d) Geometry for secondary MC simulation.
Figure 3Mean DSB yields per Cell per Gy for (a) anoxic condition (0% Oxygen) and (b) normoxic condition (21% Oxygen).
Figure 4Parameter sensitivity analysis of TLK model.
(a) Pair-wise interaction Probability, η. (b) probability of lethal mis-repair of sDSB, β1. (c) Probability of lethal mis-repair of cDSB, β2.
Figure 5Isodose distribution of the lung cancer patient.
The location of two chosen voxels is identified using star marks.
Radiation features of two chosen voxels under normoxic condition (21%).
| Isocenter Voxel | Peripheral Voxel | |
|---|---|---|
| Macroscopic Features of the Voxel: | ||
| Density (g/cm3) | 1.07 | 0.28 |
| Material | Soft tissue | Lungs inhale |
| Mean Energy of incident electron (keV) | 656 | 594 |
| Mean Energy of incident photon (keV) | 1292 | 1197 |
| Voxel Dose from TPS (Gy) | 2.21 | 2.12 |
| Voxel Dose from Geant4 (Gy) | 2.2 | 2.06 |
| Microdosimetric Features among all nucleus: | ||
| Fraction of electrons <100 keV (%) | 19.8 ± 3.9 | 20.6 ± 4.2 |
| Nucleus Dose (Gy) | 2.07 ± 0.50 | 1.97 ± 0.52 |
| Yield of Total DSB | 111.5 ± 24.1 | 109.8 ± 25.3 |
| Yield of cDSB | 59.6 ± 17.4 | 60.4 ± 15.2 |
| Yield of sDSB | 51.7 ± 10.1 | 50.7 ± 10.4 |
| Survival Factor per Fraction: | ||
| SF_LQ (%) | 51.7 | 54.3 |
| SF_MC(%, 24 h) | 55.8 ± 0.5 | 57.9 ± 0.4 |
aSurvival fraction calculated by LQ model using the macroscopic dose of the voxel.
bSurvival fraction calculated in this study after 24 hours of damage repair.
cMean ± standard deviation among a number of 105 nucleus models. The values were averaged using results from three repeated simulations.
dMean and standard deviation obtained from three repeated simulations.
Figure 6(a) The survival fraction and (b) hypoxia reduction factor (HRF) under various oxygen concentrations of the isocenter voxel after a single fraction irradiation.
Radiation features of six spectra irradiations under normoxic condition (21%).
| 50 kV | 250 kV | 500 kV | 1 MV | 3 MV | 6 MV | |
|---|---|---|---|---|---|---|
| Mean photon energy (kV) | 30.50 | 123.80 | 184.80 | 375.10 | 897.50 | 1871.00 |
| Fraction of electrons <100 keV (%) | 100 ± 0.33 | 98.43 ± 1.69 | 78.12 ± 4.81 | 33.89 ± 4.68 | 15.93 ± 2.93 | 9.53 ± 1.79 |
| Nucleus Dose (Gy) | 0.93 ± 0.20 | 0.92 ± 0.14 | 0.9 ± 0.13 | 0.87 ± 0.11 | 0.85 ± 0.09 | 0.85 ± 0.09 |
| Yield of Total DSB | 52.54 ± 11.67 | 49.86 ± 7.64 | 48.02 ± 6.81 | 45.47 ± 5.94 | 44.95 ± 5.12 | 44.77 ± 4.85 |
| Yield of cDSB | 31.42 ± 5.00 | 28.61 ± 4.24 | 26.4 ± 3.79 | 24.64 ± 3.34 | 24.02 ± 2.95 | 23.33 ± 2.78 |
| Yield of sDSB | 23.12 ± 4.77 | 23.26 ± 3.44 | 21.62 ± 3.06 | 20.64 ± 2.64 | 20.77 ± 2.29 | 21.44 ± 2.11 |
| Fraction of cDSB | 0.60 | 0.57 | 0.55 | 0.54 | 0.53 | 0.52 |
| SF_MC(%, 24 h) | 75.63 ± 0.71 | 78.27 ± 0.75 | 79.02 ± 0.74 | 79.48 ± 0.77 | 80.13 ± 0.75 | 80.66 ± 0.79 |
| Relative Biological Effectiveness | 1.26 | 1.12 | 1.09 | 1.06 | 1.03 | 1.00 |
aThe survival fraction calculated in this study after 24 hours of damage repair.
bRBE is cell survival fraction compared to results of 6MV photon beam. The values were averaged using results from three repeated simulations.